Myriad Genetics (MYGN) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.14 +7.25%
Revenue Growth %: -7.0%
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -7.0%
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $173.1 million versus the consensus estimate of $156.2 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Astrana Health (ASTH) Mentioned as short at Glass House
- Nucor projects Q3 2026 earnings above prior year, below estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
